Faculty of Medicine

Immunotherapy for head and neck tumours

Immunotherapy treatments are being used with increasing success to treat patients with advanced forms of cancer. An international team of researchers involving the West German Cancer Centre and the Faculty of Medicine were able to prove for the first time that the immuno-stimulating antibody nivolumab is more effective than traditional chemotherapy for reducing head and neck tumours. In addition, the quality of life of those affected can be maintained for a significantly longer period using immunotherapy.